Canonical and cross-reactive binding of NK cell inhibitory receptors to HLA-C allotypes is dictated by peptides bound to HLA-C

Frontiers in Immunology

Volumn 8, Issue MAR, 2017, Pages

  Sim, Malcolm J W ^a,b   Malaker, Stacy A ^c,d   Khan, Ayesha ^b   Stowell, Janet M ^b   Shabanowitz, Jeffrey ^c   Peterson, Mary E ^a   Rajagopalan, Sumati ^a   Hunt, Donald F ^c,e   Altmann, Daniel M ^b   Long, Eric O ^a   Boyton, Rosemary J ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF VIRGINIA   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Human leukocyte antigen; Immunogenetics; Innate immunity; Killer cell Ig like receptors; Natural killer cell

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3;

AMINO ACID SEQUENCE; ARTICLE; CANONICAL ANALYSIS; CELL FUNCTION; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN EXPRESSION;

EID: 85017167240     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00193     Document Type: Article

References (56)

1. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol (2001) 1:41-9. doi: 10.1038/35095564
2. Long EO, Sik Kim H, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 31:227-58. doi:10.1146/annurev-immunol-020711-075005
3. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol (2005) 5:201-14. doi:10.1038/nri1570
4. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, et al. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med (1995) 182:605-9. doi:10.1084/jem.182.2.605
5. Winter CC, Long EO. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol (1997) 158:4026-8.
6. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol (2007) 149:1-8. doi:10.1111/j.1365-2249.2007.03424.x
7. Boyton RJ, Altmann DM. Bronchiectasis: current concepts in pathogenesis, immunology, and microbiology. Annu Rev Pathol (2016) 11:523-54. doi:10.1146/annurev-pathol-012615-044344
8. Boyton RJ, Smith J, Ward R, Jones M, Ozerovitch L, Wilson R, et al. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med (2006) 173:327-33. doi:10.1164/rccm.200501-124OC
9. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 305:872-4. doi:10.1126/science.1097670
10. Hiby SE, Walker JJ, O'shaughnessy KM, Redman CW, Carrington M, Trowsdale J, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med (2004) 200:957-65. doi:10.1084/jem.20041214
11. Hiby SE, Apps R, Chazara O, Farrell LE, Magnus P, Trogstad L, et al. Maternal KIR in combination with paternal HLA-C2 regulate human birth weight. J Immunol (2014) 192:5069-73. doi:10.4049/jimmunol.1400577
12. Parham P, Moffett A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol (2013) 13:133-44. doi:10.1038/nri3370
13. Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin Immunol (2008) 20:343-52. doi:10.1016/j.smim.2008.06.003
14. Khakoo SI, Carrington M. KIR and disease: a model system or system of models? Immunol Rev (2006) 214:186-201. doi:10.1111/j.1600-065X.2006.00459.x
15. Rajagopalan S, Long EO. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med (2005) 201:1025-9. doi:10.1084/jem.20050499
16. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 295:2097-100. doi:10.1126/science.1068440
17. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood (1999) 94:333-9.
18. Cichocki F, Verneris MR, Cooley S, Bachanova V, Brunstein CG, Blazar BR, et al. The past, present, and future of NK cells in hematopoietic cell transplantation and adoptive transfer. Curr Top Microbiol Immunol (2016) 395:225-43. doi:10.1007/82_2015_445
19. Fadda L, Borhis G, Ahmed P, Cheent K, Pageon SV, Cazaly A, et al. Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci U S A (2010) 107:10160-5. doi:10.1073/pnas.0913745107
20. Zappacosta F, Borrego F, Brooks AG, Parker KC, Coligan JE. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci U S A (1997) 94:6313-8. doi:10.1073/pnas.94.12.6313
21. Rajagopalan S, Long EO. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med (1997) 185:1523-8. doi:10.1084/jem.185.8.1523
22. Holzemer A, Thobakgale CF, Jimenez Cruz CA, Garcia-Beltran WF, Carlson JM, van Teijlingen NH, et al. Selection of an HLA-C*03:04-restricted HIV-1 p24 Gag sequence variant is associated with viral escape from KIR2DL3+ natural killer cells: data from an observational cohort in South Africa. PLoS Med (2015) 12:e1001900; discussion e1001900. doi:10.1371/journal.pmed.1001900
23. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature (2011) 476:96-100. doi:10.1038/nature10237
24. Fan QR, Long EO, Wiley DC. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol (2001) 2:452-60.
25. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature (2000) 405:537-43. doi:10.1038/35014520
26. Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, et al. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med (2009) 206:2557-72. doi:10.1084/jem.20091010
27. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol (2008) 180:3969-79. doi:10.4049/jimmunol.180.6.3969
28. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol (1998) 161:571-7.
29. Hilton HG, Vago L, Older Aguilar AM, Moesta AK, Graef T, Abi Rached L, et al. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J Immunol (2012) 189:1418-30. doi:10.4049/jimmunol.1100431
30. Rasmussen M, Harndahl M, Stryhn A, Boucherma R, Nielsen LL, Lemonnier FA, et al. Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule. J Immunol (2014) 193:4790-802. doi:10.4049/jimmunol.1401689
31. York IA, Roop C, Andrews DW, Riddell SR, Graham FL, Johnson DC. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell (1994) 77:525-35. doi:10.1016/0092-8674(94)90215-1
32. Peruzzi M, Parker KC, Long EO, Malnati M. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol (1996) 157:3350-6.
33. Sim MJ, Stowell J, Sergeant R, Altmann DM, Long EO, Boyton RJ. KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells. Eur J Immunol (2016) 46:185-91. doi:10.1002/eji.201545757
34. Moesta AK, Parham P. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front Immunol (2012) 3:336. doi:10.3389/fimmu.2012.00336
35. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity (1995) 1995(3):801-9. doi:10.1016/1074-7613(95)90069-1
36. Xiong S, Sharkey AM, Kennedy PR, Gardner L, Farrell LE, Chazara O, et al. Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J Clin Invest (2013) 123:4264-72. doi:10.1172/JCI68991
37. Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A, et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest (2010) 120:4102-10. doi:10.1172/JCI43998
38. Maenaka K, Juji T, Nakayama T, Wyer JR, Gao GF, Maenaka T, et al. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J Biol Chem (1999) 274:28329-34. doi:10.1074/jbc.274.40.28329
39. Vales-Gomez M, Reyburn HT, Mandelboim M, Strominger JL. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity (1998) 9:337-44. doi:10.1016/S1074-7613(00)80616-0
40. Hilton HG, Guethlein LA, Goyos A, Nemat-Gorgani N, Bushnell DA, Norman PJ, et al. Polymorphic HLA-C receptors balance the functional characteristics of KIR haplotypes. J Immunol (2015) 195:3160-70. doi:10.4049/jimmunol.1501358
41. Frazier WR, Steiner N, Hou L, Dakshanamurthy S, Hurley CK. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand. J Immunol (2013) 190:6198-208. doi:10.4049/jimmunol.1300464
42. Béziat V, Hilton HG, Norman PJ, Traherne JA. Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T cell biology. Immunology (2017) 150:248-64. doi:10.1111/imm.12684
43. Lunemann S, Martrus G, Hölzemer A, Chapel A, Ziegler M, Körner C, et al. Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C *03:04 and modulate NK cell function. J Hepatol (2016) 65:252-8. doi:10.1016/j.jhep.2016.03.016
44. Tu M, Mahmoud AB, Makrigiannis AP. Licensed and unlicensed NK cells: differential roles in cancer and viral control. Front Immunol (2016) 7:166. doi:10.3389/fimmu.2016.00166
45. Mahmoud AB, Tu MM, Wight A, Zein HS, Rahim MM, Lee SH, et al. Influenza virus targets class I MHC-educated NK cells for immunoevasion. PLoS Pathog (2016) 12:e1005446. doi:10.1371/journal.ppat.1006021
46. Orr MT, Murphy WJ, Lanier LL. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol (2010) 11:321-7. doi:10.1038/ni.1849
47. Landtwing V, Raykova A, Pezzino G, Béziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest (2016) 126:3772-82. doi:10.1172/JCI86923
48. Cobbold M, De La Pena H, Norris A, Polefrone JM, Qian J, English AM, et al. MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Sci Transl Med (2013) 5:203ra125. doi:10.1126/scitranslmed.3006061
49. Udeshi ND, Compton PD, Shabanowitz J, Hunt DF, Rose KL. Methods for analyzing peptides and proteins on a chromatographic timescale by electron-transfer dissociation mass spectrometry. Nat Protoc (2008) 11:1709-17. doi:10.1038/nprot.2008.159
50. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaelsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood (2010) 115:1166-74. doi:10.1182/blood-2009-09-245746
51. Peterson ME, Long EO. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity (2008) 29:578-88. doi:10.1016/j.immuni.2008.07.014
52. Thomas LM, Peterson ME, Long EO. Cutting edge: NK cell licensing modulates adhesion to target cells. J Immunol (2013) 191(8):3981-5. doi:10.4049/jimmunol.1301159
53. Kumar S, Sarkar P, Sim MJ, Rajagopalan S, Vogel SS, Long EO. A single amino acid change in inhibitory killer cell Ig-like receptor results in constitutive receptor self-association and phosphorylation. J Immunol (2015) 194(2):817-26. doi:10.4049/jimmunol.1401830
54. Gumperz J. Generation of HLA class I transfected target cell lines. Methods Mol Biol (2000) 121:49-60. doi:10.1385/1-59259-044-6:49
55. Baurain JF, Coulie PG. Correction of HLA-Cw*0501 and identification of HLA-Cw*0711. Tissue Antigens (1999) 53:510-2. doi:10.1034/j.1399-0039.1999.530508.x
56. Oosten LE, Koppers-Lalic D, Blokland E, Mulder A, Ressing ME, Mutis T, et al. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes. Int Immunol (2007) 19:1115-22. doi:10.1093/intimm/dxm082